Listen to this week's edition of the "Weekly Radio Spin," the Center for Media and Democracy's audio report on the stories behind the news. This week, we look at the demise of whistleblower protections, Lipitor's new pitch man, and how to look like you're military without actually enlisting. In "Six Degrees of Spin and Fakin'," we look at the Ogilvy and Mather advertising firm. The Weekly Radio Spin is freely available for personal and broadcast use. Podcasters can subscribe to the XML feed on www.prwatch.org/audio or via iTunes. If you air the Weekly Radio Spin on your radio station, please email us at editor@prwatch.org to let us know. Thanks!

The U.S. Labor Department has only "ruled in favor of [corporate] whistleblowers 17 times out of 1,273 complaints filed since 2002," and has dismissed 841 cases. Many of the dismissals were based "on the technicality that workers at corporate subsidiaries aren't covered" by the Sarbanes-Oxley Act. The Act, passed after the Enron and Worldcom scandals, contained the first federal protections for corporate whistleblowers. Senator Patrick Leahy, who helped draft the Act, says it covers workers in corporate subsidiaries. "Otherwise," he explained, "a company that wants to do something shady, could just do it in their subsidiary." The Labor Department disagrees. One of the whistleblower cases it dismissed involves communications giant WPP. A former staffer at WPP's ad firm Ogilvy & Mather claims he was fired "in retaliation for his cooperation with a federal criminal investigation into his employer's billing practices." Two former Ogilvy executives received prison sentences for overbilling the U.S. government, but the staffer's whistleblower complaint was dismissed. Even though WPP describes its firms as "centrally integrated," the Labor Department ruled that Ogilvy is a subsidiary not covered by Sarbanes-Oxley.

Corporate-funded "educational" materials about healthy eating distributed to British schools have been criticized by Britain's Food Standards Agency, the Department of Health and dieticians' groups. "It's bad nutritional advice, which could give children wrong ideas about food at a very impressionable time," said Richard Watts of the Children's Food Campaign. The campaign is "assembling a dossier" on such materials, to prod the government to act. One pamphlet from the British Soft Drinks Association cautions students against refilling soda bottles with tap water, claiming it's "unsafe" and "can lead to contamination." A Dairy Council leaflet urges "three to four servings of milk, yoghurt or cheese" to "ensure that teenagers get all the calcium they need." Other sponsored materials direct students "to eat six slices of bread a day," claim that eating cheese "will soon have you a lot healthier," and compare soft drinks to "rice, pasta and bread."

From Pfizer's new Lipitor adPfizer's getting ready to resume advertising for its cholesterol drug Lipitor. In February, the drugmaker pulled its Lipitor ads, over charges they were misleading. The old ads featured artificial heart inventor Robert Jarvik, who appeared to be giving medical advice though he isn't a practicing physician. The new ads feature "John E.," a baby boomer and heart-attack survivor who "didn't take a cholesterol-fighting drug before his heart attack ... despite a history of high cholesterol." A Pfizer marketing executive said, "When we did testing with consumers ... John really resonated with them." But will the ad boost sales? According to a new study, the impact of direct-to-consumer (DTC) drug advertising on sales is "highly variable" and, for two of the three drugs studied, the ads "had no apparent impact." The study, which was published in the British Medical Journal, compared drug sales in French-speaking versus English-speaking Canadian provinces. Like most countries, Canada bans DTC ads, but Canadian viewers still see them via U.S. television. Advertising executives maintain that DTC ads do boost sales. "Had anyone ever heard of erectile dysfunction or overactive bladder before the drugs were advertised?" asked one.

The second-largest U.S. oil company sees itself as a victim, and it's going on a PR offensive to explain why. In an "unusual move," Chevron "has approached the media to offer a briefing" on an upcoming civil trial, "in which it faces charges of wrongful death, civil conspiracy, torture and negligence." The case, Bowoto versus Chevron, was brought by Nigerian villagers and stems from a 1998 incident where the Nigerian military shot at protesters on one of Chevron's offshore platforms. The soldiers were paid by Chevron and flown to the platform in Chevron helicopters, according to EarthRights International. A U.S. district court judge recently concluded that Chevron personnel "were directly involved" in and approved of the attack. Chevron denies the charges, saying the protesters "took Chevron workers hostage and attacked law enforcement when it arrived." Chevron has hired Singer Associates, the San Francisco PR firm that defended the city zoo after one of its tigers escaped its enclosure and killed one person. Chevron's PR push is part of a trend of companies doing more media work around legal cases. The traditional "'no comment' approach" yields "the entire dialog to the other side," explained PR executive Erin Powers.

Sears-Army clothing logo (from Advertising Age)Sears has entered into a first-ever deal with the United States Military to market a new line of officially sanctioned, military-styled clothing to men, women and boys. The military has officially licensed a "soldier chic" line of clothing to Sears called the "All American Army Brand First Infantry Division" collection. The garb, to be launched in 550 Sears stores in October -- just in time for the holiday season -- consists of "authentic lifestyle reinterpretations" of regulation uniforms and military-issued gear like T-shirts, hooded sweatshirts, denim and other outerwear. The partnership is part of a marketing strategy to raise the public profile of the U.S. military. Sears already carries some military-themed merchandise on its Web site, like a Modern Military Figure Special Forces Soldier toy for ages 8 and up, a musical DVD titled "Death Chants, Breakdowns and Military Waltzes, Vol. 2," which lists song titles like "Cadaver Recovery Man" and "Mud & Guts," and a Self-esteem Zip Military Style Vest for Juniors.

The Colombian government will pay U.S. lobbyist Andrew J. Samet another $45,000, "to present Colombia's track record on labor issues to Congress, non-governmental organizations and labor unions." The new contract is similar to Samet's earlier work to push the U.S. - Colombia Free Trade Agreement, on which the Center for Media and Democracy previously reported. Samet served as deputy under secretary for labor under President Bill Clinton and later co-founded the Sorini, Samet & Associates lobbying firm. Samet "was responsible for the North American Agreement on Labor Cooperation," an addition to the North American Free Trade Agreement with Mexico and Canada meant to address concerns about workers rights.

MoveOn, Media Matters and liberal blogs have launched a campaign against Associated Press Washington bureau chief Ron Fournier, "for what they consider light treatment of John McCain at the expense of other candidates -- especially Barack Obama." In response, AP vice president for corporate communications Ellen Hale sent "elections coverage talking points" to AP managers. Hale suggests pointing to AP's ethics policies, which require reporters to "avoid any political activity, whether they cover politics or not." The talking points cover Fournier's experience and his statement expressing "regret" at "the breezy nature" of a 2004 email to Republican strategist Karl Rove in which Fournier wrote, "Keep up the fight." The talking points also stress when Fournier held different roles at AP and when he worked for the political website HOTSOUP.com. "Later this week," Hale adds, AP "Corporate Communications will go live with a robust new Elections page ... that will provide some real estate to deal with these issues. ... Some of the blogs now are also picking up the drumbeat of dissatisfaction with AP that some members have been voicing with the roll-out of Member choice," a new pricing system for AP content.

Screen capture of a TV ad for Vytorin, taken from YouTubeThree million people worldwide are taking the new, heavily advertised anti-cholesterol drugs Zetia and Vytorin, despite a lack of clinical evidence that they reduce cardiovascular disease or heart attacks, or help patients live longer. Vytorin and Zetia brought in $5.2 billion last year for Merck and Schering-Plough, placing them among the best-selling drugs in the world. The Food and Drug Administration approves many drugs based on whether they perform a specific action, like lowering cholesterol, without requiring long-term trials on whether they extend life or lower disease risks. Other FDA-approved drugs have been found to be ineffective or even dangerous. A possible link between Vytorin and cancer cannot be proved or ruled out after three studies, reports AP. In 1999, the FDA approved the diabetes drug Avandia, because it lowered blood sugar; it was later found to increase heart attacks. But pharmaceutical companies oppose changing the current system. Ken Johnson, senior vice president of the Pharmaceutical Research and Manufacturers of America, says the FDA's approach enables patients "to access life-saving and life-enhancing remedies more quickly."